-transparent.png){kind=logo}
We report the case history of a 35-year-old male patient with lymphoblastic non-Hodgkin's lymphoma who acquired a systemic infection with Fusarium nygamai during the granulocytopenic phase of cytostatic treatment. The patient survived this infection after haematological recovery and treatment with intravenous amphotericin B (total dose 543 mg). Subsequent chemotherapy courses were not complicated by fungal infections. A recent trip to Egypt and severe chemotherapy-induced mucositis were probably the major causes of this severe infection.
Related Publications
J W Krulder, and
R W Brimicombe, and
P W Wijermans, and
W Gams
September 2000,
Research initiative, treatment action : RITA,
J W Krulder, and
R W Brimicombe, and
P W Wijermans, and
W Gams
December 2015,
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,
J W Krulder, and
R W Brimicombe, and
P W Wijermans, and
W Gams
October 2003,
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
J W Krulder, and
R W Brimicombe, and
P W Wijermans, and
W Gams
April 1995,
Genitourinary medicine,
J W Krulder, and
R W Brimicombe, and
P W Wijermans, and
W Gams
May 2001,
Leukemia & lymphoma,
J W Krulder, and
R W Brimicombe, and
P W Wijermans, and
W Gams
July 2006,
The American journal of tropical medicine and hygiene,
J W Krulder, and
R W Brimicombe, and
P W Wijermans, and
W Gams
December 2023,
Ear, nose, & throat journal,
J W Krulder, and
R W Brimicombe, and
P W Wijermans, and
W Gams
February 2002,
Retina (Philadelphia, Pa.),
J W Krulder, and
R W Brimicombe, and
P W Wijermans, and
W Gams
April 1992,
British journal of rheumatology,
J W Krulder, and
R W Brimicombe, and
P W Wijermans, and
W Gams
October 1996,
British medical bulletin,
